Abstract
We focused our attention on brahma-related gene 1 (BRG1), the ATPase subunit of the SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeling complex, and analyzed its role in mesenchymal stem cell (MSC) biology. We hypothesized that deviation from the correct concentration of these proteins, which act at the highest level of gene regulation, may be deleterious for cells. We wanted to know what would happen if a cell had to cope with altered regulation of gene expression, either by upregulation or downregulation of BRG1. We assumed that cells would try to restore homeostasis or, alternatively, that the event could trigger senescence/apoptosis phenomena. To this end, in MSCs, we silenced BRG1gene. Knockdown of BRG1 expression induced a significant increase in senescent cells and decrease in apoptotic cells. It is interesting that BRG1 downregulation also induced an increase in heterochromatin. At the molecular level, these phenomena were associated with activation of retinoblastoma-like protein 2 (RB2)/P130- and P53-related pathways. Senescence was accompanied by reduced expression of some stemness-related genes. This is consistent with our previous research, which showed that BRG1 upregulation by ectopic expression also induced senescence processes. Together, these data suggest that BRG1 belongs to a class of genes whose expression is tightly regulated; hence, subtle alterations in BRG1 activity seem to negatively affect mechanisms regulating chromatin status and, in turn, impair cellular physiology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Alves H, Munoz-Najar U, de Wit J, Renard AJ, Hoeijmakers JH, Sedivy JM et al. (2009). A link between the accumulation of DNA damage and loss of multipotency of human mesenchymal stromal cells. J Cell Mol Med (e-pub ahead of print).
Beyer Nardi N, da Silva Meirelles L . (2006). Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol 174: 249–282.
Bode AM, Dong Z . (2004). Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4: 793–805.
Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A et al. (2000). A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 6: 1287–1295.
Campisi J, d'Adda di Fagagna F . (2007). Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729–740.
Collado M, Blasco MA, Serrano M . (2007). Cellular senescence in cancer and aging. Cell 130: 223–233.
de la Serna IL, Ohkawa Y, Imbalzano AN . (2006). Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat Rev Genet 7: 461–473.
Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O . (2009). Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4: 1798–1806.
Diggle CP, Bentley J, Kiltie AE . (2003). Development of a rapid, small-scale DNA repair assay for use on clinical samples. Nucleic Acids Res 31: e83.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315–317.
Dornan D, Shimizu H, Burch L, Smith AJ, Hupp TR . (2003). The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53. Mol Cell Biol 23: 8846–8861.
Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J et al. (1994). The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79: 119–130.
Felsani A, Mileo AM, Paggi MG . (2006). Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene 25: 5277–5285.
Fotedar R, Bendjennat M, Fotedar A . (2004). Role of p21WAF1 in the cellular response to UV. Cell Cycle 3: 134–137.
Gage FH . (2000). Mammalian neural stem cells. Science 287: 1433–1438.
Galderisi U, Cipollaro M, Giordano A . (2006). The retinoblastoma gene is involved in multiple aspects of stem cell biology. Oncogene 25: 5250–5256.
Galderisi U, Di Bernardo G, Cipollaro M, Peluso G, Cascino A, Cotrufo R et al. (1999). Differentiation and apoptosis of neuroblastoma cells: role of N-myc gene product. J Cell Biochem 73: 97–105.
Giorgio M, Trinei M, Migliaccio E, Pelicci PG . (2007). Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol 8: 722–728.
Hao M, Lowy AM, Kapoor M, Deffie A, Liu G, Lozano G . (1996). Mutation of phosphoserine 389 affects p53 function in vivo. J Biol Chem 271: 29380–29385.
Harbour JW, Dean DC . (2000). Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2: E65–E67.
Hendricks KB, Shanahan F, Lees E . (2004). Role for BRG1 in cell cycle control and tumor suppression. Mol Cell Biol 24: 362–376.
Hill R, Bodzak E, Blough MD, Lee PW . (2008). p53 Binding to the p21 promoter is dependent on the nature of DNA damage. Cell Cycle 7: 2535–2543.
Hoeijmakers JH . (2001). Genome maintenance mechanisms for preventing cancer. Nature 411: 366–374.
Kang H, Cui K, Zhao K . (2004). BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI. Mol Cell Biol 24: 1188–1199.
Khanna KK, Jackson SP . (2001). DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27: 247–254.
Kholodenko BN . (2000). Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. Eur J Biochem 267: 1583–1588.
Kidder BL, Palmer S, Knott JG . (2009). SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells. Stem Cells 27: 317–328.
Lavin MF, Gueven N . (2006). The complexity of p53 stabilization and activation. Cell Death Differ 13: 941–950.
Lee D, Kim JW, Seo T, Hwang SG, Choi EJ, Choe J . (2002). SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem 277: 22330–22337.
Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E et al. (2005). p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7: 165–171.
Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW . (2005). DNA repair, genome stability, and aging. Cell 120: 497–512.
Lu H, Fisher RP, Bailey P, Levine AJ . (1997). The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro. Mol Cell Biol 17: 5923–5934.
Maison C, Almouzni G . (2004). HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol 5: 296–304.
Marsden VS, Kaufmann T, O'Reilly L A, Adams JM, Strasser A . (2006). Apaf-1 and caspase-9 are required for cytokine withdrawal-induced apoptosis of mast cells but dispensable for their functional and clonogenic death. Blood 107: 1872–1877.
Martens JA, Winston F . (2003). Recent advances in understanding chromatin remodeling by Swi/Snf complexes. Curr Opin Genet Dev 13: 136–142.
Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K et al. (2007). Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9: 625–635.
Matoba R, Niwa H, Masui S, Ohtsuka S, Carter MG, Sharov AA et al. (2006). Dissecting Oct3/4-regulated gene networks in embryonic stem cells by expression profiling. PLoS ONE 1: e26.
Matsumoto S, Banine F, Struve J, Xing R, Adams C, Liu Y et al. (2006). Brg1 is required for murine neural stem cell maintenance and gliogenesis. Dev Biol 289: 372–383.
Mikkers H, Frisen J . (2005). Deconstructing stemness. EMBO J 24: 2715–2719.
Morales M, Theunissen JW, Kim CF, Kitagawa R, Kastan MB, Petrini JH . (2005). The Rad50S allele promotes ATM-dependent DNA damage responses and suppresses ATM deficiency: implications for the Mre11 complex as a DNA damage sensor. Genes Dev 19: 3043–3054.
Moran E . (1993). Interaction of adenoviral proteins with pRB and p53. FASEB J 7: 880–885.
Morrison SJ, Shah NM, Anderson DJ . (1997). Regulatory mechanisms in stem cell biology. Cell 88: 287–298.
Muller-Sieburg CE, Deryugina E . (1995). The stromal cells’ guide to the stem cell universe. Stem Cells 13: 477–486.
Murphy DJ, Hardy S, Engel DA . (1999). Human SWI-SNF component BRG1 represses transcription of the c-fos gene. Mol Cell Biol 19: 2724–2733.
Naidu SR, Love IM, Imbalzano AN, Grossman SR, Androphy EJ . (2009). The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene 28: 2492–2501.
Napolitano MA, Cipollaro M, Cascino A, Melone MA, Giordano A, Galderisi U . (2007). Brg1 chromatin remodeling factor is involved in cell growth arrest, apoptosis and senescence of rat mesenchymal stem cells. J Cell Sci 120: 2904–2911.
Narita M, Nunez S, Heard E, Lin AW, Hearn SA, Spector DL et al. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703–716.
Oberdoerffer P, Sinclair DA . (2007). The role of nuclear architecture in genomic instability and ageing. Nat Rev Mol Cell Biol 8: 692–702.
Prockop DJ . (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71–74.
Rajagopalan S, Jaulent AM, Wells M, Veprintsev DB, Fersht AR . (2008). 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers. Nucleic Acids Res 36: 5983–5991.
Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA . (2002). ‘Stemness’: transcriptional profiling of embryonic and adult stem cells. Science 298: 597–600.
Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser Jr W, Murchardt C et al. (2002). Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene 21: 1196–1207.
Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A . (2004). Rational siRNA design for RNA interference. Nat Biotechnol 22: 326–330.
Ronen A, Glickman BW . (2001). Human DNA repair genes. Environ Mol Mutagen 37: 241–283.
Saha A, Wittmeyer J, Cairns BR . (2006). Chromatin remodelling: the industrial revolution of DNA around histones. Nat Rev Mol Cell Biol 7: 437–447.
Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A et al. (1998). DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12: 2831–2841.
Sethe S, Scutt A, Stolzing A . (2006). Aging of mesenchymal stem cells. Ageing Res Rev 5: 91–116.
Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN et al. (2000). BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci USA 97: 7748–7753.
Takahashi K, Yamanaka S . (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663–676.
Temple S . (2001). The development of neural stem cells. Nature 414: 112–117.
Trotter KW, Archer TK . (2008). The BRG1 transcriptional coregulator. Nucl Recept Signal 6: e004.
von Zglinicki T, Burkle A, Kirkwood TB . (2001). Stress, DNA damage and ageing—an integrative approach. Exp Gerontol 36: 1049–1062.
Wang HG, Moran E, Yaciuk P . (1995). E1A promotes association between p300 and pRB in multimeric complexes required for normal biological activity. J Virol 69: 7917–7924.
Wang HG, Yaciuk P, Ricciardi RP, Green M, Yokoyama K, Moran E . (1993). The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300. J Virol 67: 4804–4813.
Wesierska-Gadek J, Schmid G . (2005). The subcellular distribution of the p53 tumour suppressor, and organismal ageing. Cell Mol Biol Lett 10: 439–453.
Yu K, Ganesan K, Tan LK, Laban M, Wu J, Zhao XD et al. (2008). A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers. PLoS Genet 4: e1000129.
Zhang J, Niu C, Ye L, Huang H, He X, Tong WG et al. (2003). Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425: 836–841.
Acknowledgements
This work was partially supported by SHRO funds to UG and AG. We thank Maria Rosaria Cipollaro for technical assistance. We thank Dr Francesca Pentimalli for helpful discussion.
Author contributions: Tiziana Squillaro: conception and design, performed experiments; Nicola Alessio: conception and design, performed experiments; Marilena Cipollaro: assembly of data, data analysis and interpretation; Luigi Bagella: provision of study material, data analysis and interpretation and financial support; Antonio Giordano: conception and design, data analysis and interpretation and financial support; Umberto Galderisi: conception and design, data analysis and interpretation, paper writing and financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Alessio, N., Squillaro, T., Cipollaro, M. et al. The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB–P53 pathways. Oncogene 29, 5452–5463 (2010). https://doi.org/10.1038/onc.2010.285
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.285
Keywords
This article is cited by
-
ATP-dependent chromatin remodelers in ageing and age-related disorders
Biogerontology (2021)
-
Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway
Cell Death & Disease (2017)
-
Epigenetic Modifications upon Senescence of Mesenchymal Stem Cells
Current Stem Cell Reports (2016)
-
Senescence suppressors: their practical importance in replicative lifespan extension in stem cells
Cellular and Molecular Life Sciences (2014)
-
Insulin-like growth factor binding proteins 4 and 7 released by senescent cells promote premature senescence in mesenchymal stem cells
Cell Death & Disease (2013)